The jab uses mRNA technology to tell the immune system to recognise a ‘foreign’ protein on viruses and mount an attack.

A vaccine is to be trialled on thousands of people to find out if it could protect against norovirus - a stomach bug that causes vomiting and diarrhoea. The easily spreadable winter virus can affect people of all ages and have huge consequences - often closing hospital wards, taking children out of school and keeping parents off work.

A new trial that aims to protect against norovirus, a highly contagious stomach bug that causes vomiting and diarrhoea, is set to be trialled on 25,000 people. Norovirus, commonly referred to as the “winter vomiting bug”, affects people of all ages and has had significant societal and healthcare impacts.

The first norovirus vaccine could soon be rolled out across the UK - but what symptoms should we look out for in the meantime?

The world’s first norovirus vaccine is set to be trialled by the NHS in a bid to ease the strain on already stretched hospitals.

A groundbreaking vaccine for norovirus, the notorious winter vomiting bug, is set to enter final-stage trials in the UK within the next fortnight. Developed by Moderna using mRNA technology, the jab aims to combat three major strains of the highly contagious virus.

The new mRNA vaccine from Moderna will enter final stages of testing within the next two weeks, with results so far showing it creates a “strong immune response”.

A vaccine to guard against the winter vomiting bug norovirus is set for a year-long groundbreaking NHS trial after early results showed it creates a “strong immune response”. It is hoped an effective norovirus vaccine,